Results 361 to 370 of about 5,889,184 (390)
Some of the next articles are maybe not open access.

Granulomatous Prostatitis Mimicking Prostate Cancer

Urology, 2020
Multiparametric magnetic resonance imaging plays an important role in the detection of clinically significant prostate cancer. However, there is some overlap between prostate cancer and granulomatous prostatitis. We describe the imaging features of granulomatous prostatitis, which frequently mimics prostate cancer, and differential diagnosis between ...
Sung Kyoung, Moon   +2 more
openaire   +2 more sources

Prostate cancer

Nursing Standard, 2014
Essential facts Prostate cancer is the most common cancer in men and makes up 26 per cent of all male cancer diagnoses in the UK. According to the charity Prostate Cancer UK, more than 40,000 men are diagnosed with the disease every year. However, prostate cancer can be slow growing and many men have a cancer that will not cause them harm in their ...
openaire   +2 more sources

Prostate cancer — chemoprevention

European Journal of Cancer, 2009
Cancer prevention has been sub-classified as follows: • Primary prevention: intervention to prevent the occurrence of cancer in healthy people. • Secondary prevention: intervention in the subclinical phase, no cancer diagnosed, prevent disease in an ‘at risk’ population. • Tertiary prevention: alter the course of minimal clinical disease.
Schröder, Fritz, van Weerden, Wytske
openaire   +2 more sources

Prostatitis and prostate cancer: Implications for prostate cancer screening

Urology, 2004
Measurement of serum prostate-specific antigen (PSA) levels has become the most important single clinical test in the screening for prostate cancer. The possibility that prostatic inflammation (even in asymptomatic men) may substantially elevate PSA values is an important clinical problem, especially given the vagaries of prostate cancer ...
Jun, Kawakami   +2 more
openaire   +2 more sources

Prostate cancer screening

Comprehensive Therapy, 2005
Prostate cancer is the leading noncutaneous cancer in men of the Western world. Because of its prevalence and ability to cause morbidity and mortality,prostate cancer screening continues to be an important area of focus in health care. This article covers the sensitivity and specificity of prostate-specific antigen and current techniques used to ...
openaire   +2 more sources

NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

The Journal of the National Comprehensive Cancer Network, 2022
E. Schaeffer   +37 more
semanticscholar   +1 more source

Prostate cancer

Critical Reviews in Oncology/Hematology, 1998
L, Repetto, C, Granetto, R R, Hall
openaire   +2 more sources

Prostate cancer and chronic prostatitis

Current Prostate Reports, 2007
Prostate cancer and chronic prostatitis are prevalent disorders in men. The cause of prostate cancer and chronic prostatitis is multifocal and diverse. Both disorders exhibit characteristic elevation of serum prostate-specific antigen, currently the primary screening test for prostate cancer.
openaire   +2 more sources

Prostate cancer screening

Pathology, 2012
Prostate cancer is a slowly progressing but potentially lethal disease. In order to cure it we must detect it while it remains organ confined. Because of the slow course of the disease, prostate cancer screening trials take a long time to show any benefit and in that time the measurement and interpretation of prostate specific antigen (PSA ...
openaire   +2 more sources

PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

Science, 1997
Jing Li   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy